MainAn IND application is submitted to the FDA to request permission to conduct U.S. clinical trials using investigational products. Commercial INDs reflect new products under development while Research INDs reflect work being done to support research and public health initiatives. <br>These measures have been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research. </b> NumberMeasure was implemented starting January 2010

Jan 201025Feb 201053Mar 201056Apr 201055May 201048Jun 201043Jul 201053Aug 201046Sep 201039

FY 2011 Total: 648

Oct 201057Nov 201060Dec 201067Jan 201134Feb 201144Mar 201173Apr 201148May 201150Jun 201164Jul 201146Aug 201152Sep 2011532080

FY 2012 YTD: 208

Oct 201171Nov 201170Dec 201167Jan 2012Feb 2012Mar 2012Apr 2012May 2012Jun 2012Jul 2012Aug 2012Sep 2012http://www.fda.gov/AboutFDA/Transparency/track/ucm206444.htmFDA-TRACK CDER DashboardMainAn IND application is submitted to the FDA to request permission to conduct U.S. clinical trials using investigational products. Commercial INDs reflect new products under development while Research INDs reflect work being done to support research and public health initiatives.NumberMeasure was implemented starting January 2010

Jan 2010132Feb 2010159Mar 2010181Apr 2010195May 2010171Jun 2010160Jul 2010157Aug 2010209Sep 2010191

FY 2011 Total: 2,098

Oct 2010157Nov 2010159Dec 2010152Jan 2011196Feb 2011214Mar 2011235Apr 2011174May 2011184Jun 2011153Jul 2011160Aug 2011179Sep 2011135250

FY 2012 YTD: 432

Oct 2011149Nov 2011135Dec 2011148Jan 2012Feb 2012Mar 2012Apr 2012May 2012Jun 2012Jul 2012Aug 2012Sep 2012